GHRP-2
Also known as: Pralmorelin, Growth hormone releasing peptide-2, KP-102
Classification
Peptide
Regulatory Status
not-established
Sources
3
Review
n/a
Overview
GHRP-2 (pralmorelin) is a synthetic hexapeptide ghrelin-receptor agonist that stimulates pituitary growth hormone release and has been studied as a diagnostic secretagogue.
Evidence and limitations
Human/preclinical evidence breakdown is not available in this record.
Pathways
Interactions & cautions
Flagged in source data
CJC-1295 or other GH secretagogues without clinical rationale
Drug interactions
other GH secretagogues or GHRH analogs — Overlapping pharmacology and safety burden. (review)
These are observational flags for review, not individualized instructions.
Sources
Educational reference only — not medical advice.
What people report (anecdote)
CLINICAL DATA (from trials)
Adverse events:
None recorded in our sources.
Effects measured:
Human trials: none found.
ANECDOTE
What people report: anecdote, not evidence
Loading…
Submit a claim you saw